RU2013158422A - METHOD FOR REMOVING TUMOR NECROSIS FACTOR FROM BIOLOGICAL LIQUIDS USING MAGNETIC CONTROLLED GRANULES - Google Patents

METHOD FOR REMOVING TUMOR NECROSIS FACTOR FROM BIOLOGICAL LIQUIDS USING MAGNETIC CONTROLLED GRANULES Download PDF

Info

Publication number
RU2013158422A
RU2013158422A RU2013158422/14A RU2013158422A RU2013158422A RU 2013158422 A RU2013158422 A RU 2013158422A RU 2013158422/14 A RU2013158422/14 A RU 2013158422/14A RU 2013158422 A RU2013158422 A RU 2013158422A RU 2013158422 A RU2013158422 A RU 2013158422A
Authority
RU
Russia
Prior art keywords
necrosis factor
tumor necrosis
magnetic controlled
biological liquids
removing tumor
Prior art date
Application number
RU2013158422/14A
Other languages
Russian (ru)
Inventor
Илья Петрович Гонтарь
Андрей Степанович Трофименко
Ольга Владиславовна Парамонова
Евгений Владимирович Баранов
Ирина Александровна Зборовская
Original Assignee
Федеральное государственное бюджетное учреждение "Научно-исследовательский институт клинической и экспериментальной ревматологии" Российской Академии медицинских наук
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение "Научно-исследовательский институт клинической и экспериментальной ревматологии" Российской Академии медицинских наук filed Critical Федеральное государственное бюджетное учреждение "Научно-исследовательский институт клинической и экспериментальной ревматологии" Российской Академии медицинских наук
Priority to RU2013158422/14A priority Critical patent/RU2013158422A/en
Publication of RU2013158422A publication Critical patent/RU2013158422A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Способ снижения содержания фактора некроза опухоли, включающий пропускание биологических жидкостей через гранулированный препарат с иммобилизированными антителами к фактору некроза опухоли, отличающийся тем, что для иммобилизации антител к фактору некроза опухоли используют полиакриламидный носитель с магнитными свойствами при соотношении носитель : железо 2:1, который гранулируют методом эмульсионной полимеризации.A method of reducing the content of tumor necrosis factor, including passing biological fluids through a granular preparation with immobilized antibodies to tumor necrosis factor, characterized in that a polyacrylamide carrier with magnetic properties is used to immobilize antibodies to the tumor necrosis factor with a carrier: iron ratio of 2: 1, which is granulated emulsion polymerization method.

Claims (1)

Способ снижения содержания фактора некроза опухоли, включающий пропускание биологических жидкостей через гранулированный препарат с иммобилизированными антителами к фактору некроза опухоли, отличающийся тем, что для иммобилизации антител к фактору некроза опухоли используют полиакриламидный носитель с магнитными свойствами при соотношении носитель : железо 2:1, который гранулируют методом эмульсионной полимеризации. A method of reducing the content of tumor necrosis factor, including passing biological fluids through a granular preparation with immobilized antibodies to tumor necrosis factor, characterized in that a polyacrylamide carrier with magnetic properties is used to immobilize antibodies to the tumor necrosis factor with a carrier: iron ratio of 2: 1, which is granulated emulsion polymerization method.
RU2013158422/14A 2013-12-26 2013-12-26 METHOD FOR REMOVING TUMOR NECROSIS FACTOR FROM BIOLOGICAL LIQUIDS USING MAGNETIC CONTROLLED GRANULES RU2013158422A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2013158422/14A RU2013158422A (en) 2013-12-26 2013-12-26 METHOD FOR REMOVING TUMOR NECROSIS FACTOR FROM BIOLOGICAL LIQUIDS USING MAGNETIC CONTROLLED GRANULES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2013158422/14A RU2013158422A (en) 2013-12-26 2013-12-26 METHOD FOR REMOVING TUMOR NECROSIS FACTOR FROM BIOLOGICAL LIQUIDS USING MAGNETIC CONTROLLED GRANULES

Publications (1)

Publication Number Publication Date
RU2013158422A true RU2013158422A (en) 2015-07-10

Family

ID=53538073

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013158422/14A RU2013158422A (en) 2013-12-26 2013-12-26 METHOD FOR REMOVING TUMOR NECROSIS FACTOR FROM BIOLOGICAL LIQUIDS USING MAGNETIC CONTROLLED GRANULES

Country Status (1)

Country Link
RU (1) RU2013158422A (en)

Similar Documents

Publication Publication Date Title
AR107988A1 (en) METHODS OF USE OF SUPERABSORBENT POLYMERS FOR ARENA FRACTURE AND CONTROL APPLICATIONS
SA522431756B1 (en) Antibodies to Tigit
MX2017004311A (en) Glucocorticoid-induced tumor necrosis factor receptor (gitr) antibodies and methods of use thereof.
EA201291230A1 (en) METHODS RELATED TO APPLICATION OF LIQUIDS WITH HIGH CONTENT OF SOLID PHASE IN OIL INDUSTRY
EA201600252A1 (en) MODIFIED ANTIBODIES TO RECEPTORS OF ANTIEPIDERMAL GROWTH FACTOR AND METHODS FOR THEIR USE
EA201300978A1 (en) ANTIBODIES TO CEA
EA201791139A1 (en) HETERODIMERNYE ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
EA201492101A1 (en) ANTIBODIES AGAINST FCRN
MX2015011957A (en) Anti-tnf-anti-il-17 bispecific antibodies.
MX359794B (en) Anti-hepcidin antibodies and uses thereof.
EA201790882A1 (en) METHODS AND COMPOSITIONS FOR LIVER CANCER THERAPY
EA201690958A1 (en) DEPRESSANTS FOR USE IN DIVISION METHODS
CL2016002257A1 (en) Anti-mcam antibodies and associated methods of use
EA201391312A1 (en) ANTIBODY TO THE HUMAN TISSUE FACTOR AND ITS APPLICATION
PH12015502601A1 (en) ANTI-TNF-a/CXCL10 DOUBLE-TARGETING ANTIBODY AND USE THEREOF
EA201590420A1 (en) METHOD FOR REMOVAL OF HYDROGEN AND / OR SULFHYDRYL COMPOUNDS
MA44061A (en) MULTISPECIFIC ANTIBODY MOLECULES WITH SPECIFICITY FOR TNF-ALPHA, IL-17A AND IL-17F
UA116008C2 (en) Pan-ELR+ CXC CHEMOKINE ANTIBODIES
EA201491004A1 (en) APPLICATION OF PARTICLES WITH NEUTRAL DENSITY FOR ENHANCING THE RESISTANCE TO THE BARITIS SEDUCTION OF TRANSPORT AND FLUID SUSPENSIONS
EA201690036A1 (en) COMPOSITION WITH EXTENDED GRIPPING, CONTAINING CYTEHAMINE GRANULES AND METHODS FOR ITS PREPARATION AND APPLICATION
GEP20217307B (en) ANTI-TNFα-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF
EA201690992A1 (en) ANTIBODIES SPECIFIC TO FCRN
MX2016006743A (en) Spr-based bridging assay for determining the biological activity of multivalent, multispecific molecules.
EA201591720A1 (en) PROTEINS SPECIFIC IN RELATION TO BAFF AND B7RP1, AND THEIR APPLICATION
WO2015138928A3 (en) Mixed mode ligands